Moreno Aspitia A

Moreno Aspitia A

Mayo Clinic - Rochester / United States
Others
AD Scientific Index ID: 1337308
Mayo Clinic College of Medicine and Science
person_outline Moreno Aspitia A's MOST POPULAR ARTICLES
1-) Antitumor activity and safety of trastuzumab deruxtecan in patients with HER2-low–expressing advanced breast cancer: results from a phase Ib studyS Modi, H Park, RK Murthy, H Iwata, K Tamura, J Tsurutani, ...Journal of Clinical Oncology 38 (17), 1887, 20203072020
2-) Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer.EA Perez, VJ Suman, NE Davidson, JR Gralow, PA Kaufman, ...Journal of clinical oncology: official journal of the American Society of …, 20112972011
3-) Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literatureA Dispenzieri, A Moreno-Aspitia, GA Suarez, MQ Lacy, G Colon-Otero, ...Blood 104 (10), 3400-3407, 20042592004
4-) Randomized phase III trial of paclitaxel once per week compared with nanoparticle albumin-bound nab-paclitaxel once per week or ixabepilone with bevacizumab as first-line …HS Rugo, WT Barry, A Moreno-Aspitia, AP Lyss, C Cirrincione, E Leung, ...Journal of Clinical Oncology 33 (21), 2361-2369, 20152372015
5-) Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trialsR Bradley, J Braybrooke, R Gray, R Hills, Z Liu, R Peto, L Davies, ...The Lancet Oncology 22 (8), 1139-1150, 20212302021